#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer recurrent Plasma cell myeloma refractory Fibrosarcoma metastatic Malignant fibrous histiocytoma Kearns-Sayre syndrome Anti-glomerular basement membrane disease Hereditary angioedema Neuroendocrine tumour of the lung Mantle cell lymphoma Complex regional pain syndrome Chondrosarcoma metastatic Sickle cell anaemia Malformation venous Gastrointestinal neuroendocrine tumour Retinopathy of prematurity More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome Nodal marginal zone B-cell lymphoma – Trials in Disease Primary biliary cholangitis – Treatment MELAS syndrome – Diagnostics Mucopolysaccharidosis I Angiosarcoma non-metastatic – Diagnostics Focal segmental glomerulosclerosis Glomerulonephritis rapidly progressive – Treatment Choroid melanoma Factor IX deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Stearate Insulin Glargine Dornase Alfa Lomustine Rbp030.2 Proguanil Hydrochloride Bepranemab Hydroxychloroquine Sulfate Teriflunomide Romidepsin Metamizole GS-248 Gen3017 Rosuvastatin Pyruvic Acid E.coli Polysaccharide ALN-4324 Gfh925 Fondaparinux Sodium Nelarabine More therapies…

    Learn about Your Condition

    B-cell lymphoma refractory Chorea Peritoneal sarcoma Systemic scleroderma Leukoencephalopathy Biliary neoplasm Right ventricular dysfunction Diabetes insipidus Joint stabilisation Hepatorenal syndrome Respiratory failure Obesity Progressive multiple sclerosis Biliary tract operation Arteriovenous malformation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Erythema multiforme

  • Study on Severe Erythema Multiforme: Comparing Methylprednisolone Acetate and Lidocaine Hydrochloride Monohydrate with Placebo for Hospitalized Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Erythema multiforme
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Methylprednisolone Acetate
    • Prednisone
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!